SCHEMBL819786

SCHEMBL819786

O=S(=O)(O)c1ccccc1CBr

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.44
TSHR P16473 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TTR P02766 2/20 0.38
PLCG1 P19174 1/20 0.38
CYP1A2 P05177 2/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
MMP1 P03956 2/20 0.35
MMP2 P08253 2/20 0.35
MMP3 P08254 2/20 0.35
MMP9 P14780 2/20 0.35
MMP12 P39900 2/20 0.35
MMP13 P45452 2/20 0.35
MMP14 P50281 2/20 0.35
MMP8 P22894 1/20 0.35
MMP16 P51512 1/20 0.35
FABP4 P15090 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3310311 0.98 MYC (0.43) MYCTSHRSMN1; SMN2TTRPLCG1
SCHEMBL20854258 0.98 MYC (0.43) MYCTSHRSMN1; SMN2TTRPLCG1
Bromide SCHEMBL27524790 0.98 MYC (0.43) MYCTSHRSMN1; SMN2TTRPLCG1
SCHEMBL27912471 0.84 PGAM1 (0.37) MYCTSHRSMN1; SMN2TTRPLCG1
SCHEMBL313857 0.83 MYC (0.42) MYCTSHRSMN1; SMN2TTRPLCG1
SCHEMBL30555661 0.83 MYC (0.42) MYCTSHRSMN1; SMN2TTRPLCG1
SCHEMBL1148229 0.82 GAA (0.44) TSHRPLCG1CA1CA2CA4
SCHEMBL31425768 0.82 MYC (0.47) MYCTSHRSMN1; SMN2TTRPLCG1
SCHEMBL4202392 0.82 MYC (0.47) MYCTSHRSMN1; SMN2TTRPLCG1
SCHEMBL31425767 0.82 MYC (0.47) MYCTSHRSMN1; SMN2TTRPLCG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0884096-B1 Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use KOCH MEMBRANE SYSTEMS INC (US) 2005-09-14 EP claimed
US-6086764-A Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use CROSSWINDS, INC. (US) 2000-07-11 US claimed
EP-0884096-A1 Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use Crosswinds, Inc. (US) 1998-12-16 EP claimed
CN-119060221-A Sulfonic acid functionalized polymer, ion exchange membrane and application thereof 佛山绿动氢能科技有限公司 2024-12-03 CN disclosed
US-11180657-B2 Polysulfonated fluorescence dyes ATTO-TEC GMBH (DE) 2021-11-23 US disclosed
EP-3461815-B1 NOVEL POLY SULFONATED FLUORESCENCE DYES ATTO TEC GMBH (DE) 2021-03-03 EP disclosed
US-20190322870-A2 NOVEL POLYSULFONATED FLUORESCENCE DYES ATTO-TEC GMBH (DE) 2019-10-24 US disclosed
US-20190100653-A1 NOVEL POLYSULFONATED FLUORESCENCE DYES ATTO-TEC GMBH (DE) 2019-04-04 US disclosed
EP-3461814-A1 NEW POLYSULFONATED FLUORESCENT DYES ATTO-TEC GmbH (DE) 2019-04-03 EP disclosed
EP-3461815-A1 NOVEL POLY SULFONATED FLUORESCENCE DYES ATTO-TEC GmbH (DE) 2019-04-03 EP disclosed
US-9570773-B2 Fluorine-based polymer electrolyte membrane ASAHI KASEI E-MATERIALS CORPORATION (JP) 2017-02-14 US disclosed
EP-0884096-B1 Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use KOCH MEMBRANE SYSTEMS INC (US) 2005-09-14 EP disclosed
US-6133190-A SUPPORTED MERCAPTOAKYL-SUBSTITUTED POLYSTYRENESULFONATE IS USED AS A CATALYST FOR CONDENSATION OF ALDEHYDE OR KETONE WITH PHENOL TO FORM DIHYDROXY COMPOUND THE DOW CHEMICAL COMPANY (US) 2000-10-17 US disclosed
EP-1023309-A2 HIGH SURFACE DENSITY COVALENT IMMOBILIZATION OF OLIGONUCLEOTIDE MONOLAYERS Sensorchem International Corporation (CA) 2000-08-02 EP disclosed
US-6086764-A Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use CROSSWINDS, INC. (US) 2000-07-11 US disclosed
US-6051658-A A POLYSTYRENE HAVING MERCAPTOSULFONIC ACID RESIDUE, USEFUL AS CATALYST THE DOW CHEMICAL COMPANY (US) 2000-04-18 US disclosed
US-5939494-A CATALYST USEFUL FOR THE CONDENSATION OF AN ALDEHYDE OR KETONE STARTING MATERIAL WITH A PHENOL IS AN INSOLUBLE MERCAPTOSULFONIC ACID COMPOUND THE DOW CHEMICAL COMPANY (US) 1999-08-17 US disclosed
WO-1999020640-A2 HIGH SURFACE DENSITY COVALENT IMMOBILIZATION OF OLIGONUCLEOTIDE MONOLAYERS SENSORCHEM INTERNATIONAL CORPORATION (CA) 1999-04-29 WO disclosed
EP-0884096-A1 Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use Crosswinds, Inc. (US) 1998-12-16 EP disclosed
US-5463140-A Condensing aldehyde or ketone with phenol in presence of soluble or insoluble mercaptosulfonic acid compound to form geminal bisphenol moiety at each aldehyde or ketone moiety THE DOW CHEMICAL COMPANY (US) 1995-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11180657-B2 Polysulfonated fluorescence dyes CD44, ARSA, STS MYC 3726/4885TSHR 4164/4885SMN1; SMN2 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.